We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

116 hedge funds and large institutions have $639M invested in BioDelivery Sciences International, Inc. in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

58% more capital invested

Capital invested by funds: $403M → $639M (+$236M)

46% more call options, than puts

Call options by funds: $4.83M | Put options by funds: $3.31M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

4% more funds holding

Funds holding: 112 → 116 (+4)

Holders
116
Holders Change
+4
Holders Change %
+3.57%
% of All Funds
3.37%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
44
Reduced
33
Closed
20
Calls
$4.83M
Puts
$3.31M
Net Calls
+$1.51M
Net Calls Change
-$9.59M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$35M
2
State Street
State Street
Massachusetts
+$21.4M
3
ICAP
Independence Capital Asset Partners
Colorado
+$10.9M
4
CCM
Cupps Capital Management
Illinois
+$7.84M
5
Wells Fargo
Wells Fargo
California
+$7.76M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$19.4M
2
DM
Deerfield Management
New York
-$16M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.3M
4
PA
Perceptive Advisors
New York
-$5.72M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$6.4M +$5.44M +374,518 New
NCGI
27
Next Century Growth Investors
Minnesota
$6.2M +$5.27M +362,938 New
TAM
28
THB Asset Management
Connecticut
$5.91M -$981K -67,567 -16%
Marshall Wace
29
Marshall Wace
United Kingdom
$5.64M +$1.32M +91,191 +38%
PA
30
Perceptive Advisors
New York
$5.23M -$5.72M -394,000 -56%
GIM
31
Granahan Investment Management
Massachusetts
$5.21M -$3.32M -229,047 -43%
O
32
OppenheimerFunds
New York
$4.91M +$4.17M +287,020 New
CRC
33
Curi RMB Capital
Illinois
$4.74M +$1.74M +119,997 +76%
DCM
34
Driehaus Capital Management
Illinois
$4.74M +$4.02M +277,158 New
B
35
Bailard
California
$4.32M -$2.1M -145,000 -36%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$3.97M +$220K +15,171 +7%
Renaissance Technologies
37
Renaissance Technologies
New York
$3.94M +$353K +24,338 +12%
EI
38
EAM Investors
California
$3.94M -$478K -32,903 -13%
BBA
39
Baker Bros. Advisors
New York
$3.59M -$3.06M -210,984 -50%
William Blair & Company
40
William Blair & Company
Illinois
$3.32M -$214K -14,735 -7%
SC
41
Sophrosyne Capital
New York
$3.28M -$2.95M -203,100 -51%
Ameriprise
42
Ameriprise
Minnesota
$3.01M +$521K +35,865 +26%
GPGA
43
Grandeur Peak Global Advisors
Utah
$2.75M +$666K +45,875 +40%
V
44
Veritable
Delaware
$2.68M +$2.27M +156,725 New
TCIM
45
TIAA CREF Investment Management
New York
$2.62M -$60.7K -4,179 -3%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$2.38M +$499K +34,365 +33%
TAM
47
Tocqueville Asset Management
New York
$2.2M +$363K +25,000 +24%
FPC
48
Falcon Point Capital
California
$2.14M +$1.47M +101,474 +426%
BIM
49
BlackRock Investment Management
Delaware
$2.07M +$4.7K +324 +0.3%
ARTA
50
A.R.T. Advisors
New York
$1.78M +$1.51M +104,251 New
1
2
3 4 5

BDSI Hedge Fund Activity: Q3 2014 in Review

116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2014, worth a combined $639M — up 58% from $403M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BDSI positions and 20 closed out — a net gain of 4 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Invesco, adding an estimated $35M. The largest seller was Broadfin Capital, cutting an estimated $19.4M.

  • 116 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2014, up from 112 in Q2 2014.
  • Funds reported $639M of BioDelivery Sciences International, Inc. stock for Q3 2014, up 58% quarter-over-quarter.
  • 24 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2014 and 20 closed out, a net change of +4 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2014 was Invesco, an estimated $35M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $19.4M sold.

Based on aggregated 13F filings for Q3 2014.